TrialJournal of immunology (Baltimore, Md. : 1950)2015

Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.

Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.